Design and Screening of the Peptide SAMP-12aa Derived from LL-37, Which Exhibits Anti-

Jianliang Lu, Qingyu Wang, Meisong Qin, Jinfeng Dou, Youyi Xiong, Xiaolin Zhang

Abstract read

In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jianliang LuThe Department of Pharmacy, School of Biomedical and Health Sciences, Anhui Science and Technology University, Fengyang 233100, China.

Qingyu WangThe Department of Pharmacy, School of Biomedical and Health Sciences, Anhui Science and Technology University, Fengyang 233100, China.

Meisong QinThe Department of Pharmacy, School of Biomedical and Health Sciences, Anhui Science and Technology University, Fengyang 233100, China.

Jinfeng DouThe Department of Pharmacy, School of Biomedical and Health Sciences, Anhui Science and Technology University, Fengyang 233100, China.

Youyi XiongThe Department of Pharmacy, School of Biomedical and Health Sciences, Anhui Science and Technology University, Fengyang 233100, China.

Xiaolin ZhangThe Department of Pharmacy, School of Biomedical and Health Sciences, Anhui Science and Technology University, Fengyang 233100, China.ORCID 0000-0003-4062-4697

Funding

the National Natural Science Foundation of China No. 31870080the Natural Science Foundation of Anhui Provincial Department of Education No. 2022AH040231

6 · The paper itself

Abstract

The appearance of antibiotic-resistant strains of

Indexed as

CathelicidinsHelicobacter InfectionsHelicobacter pyloriImmune ToleranceCell Line, TumorDrug Evaluation, PreclinicalDrug Resistance, BacterialForkhead Transcription FactorsGastric JuiceHumansMolecular Docking SimulationT-Lymphocytes, RegulatoryCathelicidinsForkhead Transcription FactorsFOXP3 protein, humananti-H. pylori activityantimicrobial peptidecell selectivityimmunomodulatory effectsmolecular dockingregulatory T cellstranscription factor Foxp3

Identifiers

PMID41900101

DOI10.3390/molecules31061002

PMCPMC13028905

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.